NO161117C - Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.

Info

Publication number: NO161117C
Authority: NO; Norway
Prior art keywords: preparation; therapeutic active; cephalosporin derivatives; analogy procedure; active cephalosporin
Prior art date: 1980-09-25

Application number

NO813252A

Other languages

English (en)

Norwegian (no)

Other versions

NO161117B (no

NO813252L (no

Inventor

Hiroshi Sadaki

Hirokazu Narita

Hiroyuki Imaizumi

Yoshinori Konishi

Takihiro Inaba

Tatsuo Hirakawa

Hideo Taki

Masaru Tai

Yasuo Watanabe

Isamu Saikawa

Original Assignee

Toyama Chemical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-09-25

Filing date

1981-09-24

Publication date

1989-07-05

1980-09-25 Priority claimed from JP55132253A external-priority patent/JPS5758689A/ja

1980-11-12 Priority claimed from JP55158184A external-priority patent/JPS5782393A/ja

1980-12-13 Priority claimed from JP55175263A external-priority patent/JPS6052755B2/ja

1981-09-24 Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd

1982-03-26 Publication of NO813252L publication Critical patent/NO813252L/no

1989-03-28 Publication of NO161117B publication Critical patent/NO161117B/no

1989-07-05 Publication of NO161117C publication Critical patent/NO161117C/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/48—Methylene radicals, substituted by hetero rings
- C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cephalosporin Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO813252A 1980-09-25 1981-09-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater. NO161117C (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP55132253A JPS5758689A (en)	1980-09-25	1980-09-25	Novel preparation of 7-substituted or unsubstituted amino-3-substituted methylcephem carboxylic acids
JP55158184A JPS5782393A (en)	1980-11-12	1980-11-12	7-amino-3-(2-(1,2,3,4-tetrazolyl)methyl)cephem-4-carboxylic acid
JP55175263A JPS6052755B2 (ja)	1980-12-13	1980-12-13	新規セファロスポリン類

Publications (3)

Publication Number	Publication Date
NO813252L NO813252L (no)	1982-03-26
NO161117B NO161117B (no)	1989-03-28
NO161117C true NO161117C (no)	1989-07-05

Family

ID=27316463

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO813252A NO161117C (no)	1980-09-25	1981-09-24	Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.

Country Status (27)

Country	Link
US (4)	US4489072A (nl)
KR (1)	KR860000932B1 (nl)
AR (1)	AR240645A1 (nl)
AT (4)	AT375082B (nl)
AU (3)	AU550330B2 (nl)
CA (2)	CA1204735A (nl)
CH (4)	CH652129A5 (nl)
DD (2)	DD202436A5 (nl)
DE (5)	DE3152934C2 (nl)
DK (1)	DK163877C (nl)
EG (1)	EG17373A (nl)
ES (4)	ES505760A0 (nl)
FI (2)	FI75575C (nl)
FR (2)	FR2509310B1 (nl)
GB (3)	GB2089339B (nl)
HU (1)	HU185850B (nl)
IN (4)	IN155375B (nl)
IT (1)	IT1172201B (nl)
LU (1)	LU83650A1 (nl)
MX (1)	MX155025A (nl)
NL (1)	NL8104386A (nl)
NO (1)	NO161117C (nl)
NZ (1)	NZ198350A (nl)
PH (5)	PH18072A (nl)
PT (1)	PT73727B (nl)
RO (4)	RO86825B (nl)
SE (5)	SE453090B (nl)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4703046A (en) *	1978-09-08	1987-10-27	Fujisawa Pharmaceutical Co., Ltd.	Cephem compounds and processes for preparation thereof
NZ198350A (en) *	1980-09-25	1985-02-28	Toyama Chemical Co Ltd	Cephalosporins and intermediates;pharmaceutical compositions
EP0061234A3 (en) *	1981-03-05	1983-11-16	Beecham Group Plc	Cephalosporin derivatives, process for their preparation and pharmaceutical preparations containing them
US4576938A (en) *	1981-12-08	1986-03-18	Tanabe Seiyaku Co., Ltd.	Cephalosporin compound and process for preparing the same
US4618606A (en) *	1982-11-17	1986-10-21	Toyama Chemical Co., Ltd.	Antibiotic 7-(thiazolyl)-3-(pyrazinylmethyl) or (pyridazinylmethyl) cephalosporins
DK521883A (da) *	1982-11-17	1984-05-18	Toyama Chemical Co Ltd	Cephalosporinderivater, fremgangsmaade til fremstilling heraf og fremgangsmaade til fremstilling af mellemprodukter herfor
JPS6064986A (ja) *	1983-09-20	1985-04-13	Toyama Chem Co Ltd	セファロスポリン類の製造法
JPS60190783A (ja) *	1983-12-21	1985-09-28	Sumitomo Seiyaku Kk	セフエム系化合物
GB8406231D0 (en) *	1984-03-09	1984-04-11	Fujisawa Pharmaceutical Co	Cephem compounds
GB2161476B (en) *	1984-05-25	1988-01-27	Toyama Chemical Co Ltd	2-aminothiazolyl-2-methoxyimino acetamides and their use in preparing cephalosporins
AT397086B (de) *	1984-05-25	1994-01-25	Toyama Chemical Co Ltd	Verfahren zur herstellung von neuen 2-(2-aminothiazol-4-4yl)-2-(syn)-alkoxyimino- acetamiden
FI851934L (fi) *	1984-05-30	1985-12-01	Ici Plc	Kefalosporinderivat.
DE3539901A1 (de) *	1985-11-11	1987-05-14	Hoechst Ag	Cephalosporinderivate und verfahren zu ihrer herstellung
JPH064643B2 (ja) *	1985-12-20	1994-01-19	ファイザー製薬株式会社	セフアロスポリン化合物
US4692517A (en) *	1986-03-20	1987-09-08	American Home Products Corporation	C-3' acylaminooxy-7-[(2-aminothiazol-4-yl)-α-(substituted-oximino)acetyl]cephalosporin derivatives
EP0265185A3 (en) *	1986-10-21	1990-03-28	Beecham Group Plc	Cephalosporins, processes for their preparation and pharmaceutical compositions containing them
ZA877987B (en) *	1986-11-12	1988-08-31	Ici Pharma	Antibiotic compounds
DE3750673T2 (de) *	1986-11-21	1995-03-16	Ici Pharma	Cephalosporine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate.
EP0269298B1 (en) *	1986-11-21	1994-10-19	Ici Pharma	Cephalosporins, process for their preparation and pharmaceutical compositions
US4847373A (en) *	1987-02-26	1989-07-11	Bristol-Myers Company	Production of 3-allyl- and 3-butenyl-3-cephems
US5232918A (en) *	1987-07-23	1993-08-03	Imperial Chemical Industries Plc	Cephalosporin derivatives
GB8816519D0 (en) *	1987-07-23	1988-08-17	Ici Plc	Antibiotic compounds
GB8811056D0 (en) *	1988-05-10	1988-06-15	Ici Plc	Antibiotic compounds
JPH0699443B2 (ja) *	1989-09-29	1994-12-07	ファイザー製薬株式会社	セファロスポリン化合物
US6800756B2 (en) *	2002-05-03	2004-10-05	Orchid Chemicals And Pharmaceuticals, Ltd.	Method for the preparation of ceftiofur sodium and its intermediates
DE602004028111D1 (de) *	2003-04-16	2010-08-26	Sandoz Ag	Verfahren zur herstellung von cefepim
US7847093B2 (en) *	2003-04-16	2010-12-07	Sandoz Ag	Processes for the preparations of cefepime
JP2007530589A (ja) *	2004-03-26	2007-11-01	アンフォラディスカバリーコーポレーション	特定のトリアゾールを基礎とする化合物、組成物、およびそれらの使用
US8198434B2 (en)	2008-05-07	2012-06-12	Idexx Laboratories, Inc.	Process for preparing cefsulodin sodium
CA2828114A1 (en) *	2010-02-26	2011-09-01	Gary Igor DMITRIENKO	Cephalosporin derivatives useful as .beta.-lactamase inhibitors and compositions and methods of use thereof
CN102351886B (zh) *	2011-09-07	2013-10-16	山东罗欣药业股份有限公司	头孢特仑新戊酯晶体、其制备方法及含有该晶体的组合物片剂
SG11201600108PA (en)	2013-07-17	2016-02-26	Otsuka Pharma Co Ltd	Cyanotriazole compounds
CN106046026B (zh) *	2016-06-30	2018-07-06	济南康和医药科技有限公司	一种头孢特仑新戊酯的制备方法
CN112645842B (zh) *	2020-12-25	2022-08-19	复旦大学	一种氰乙酸叔丁酯的连续流制备方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB912541A (en) *	1958-03-17	1962-12-12	Nat Res Dev	Cephalosporin c compounds
DE1795484U (de)	1959-04-21	1959-09-10	Richard Langer	Quertraeger fuer laengsdraehte zum abstuetzen von pflanzen, insbesondere weinreben.
GB1032641A (en)	1962-02-16	1966-06-15	Edward Penley Abraham	Cephalosporins
GB1057883A (en) *	1962-07-11	1967-02-08	Glaxo Lab Ltd	Improvements in or relating to antibiotics
US3226384A (en)	1963-01-25	1965-12-28	Nat Res Dev	Cephalosporin ca derivatives
BE634644A (nl) *	1963-07-10
US3821206A (en) *	1966-12-15	1974-06-28	Glaxo Lab Ltd	Cephalosporins having a polyazole substituent
GB1211694A (en)	1966-12-15	1970-11-11	Glaxo Lab Ltd	Derivatives of 7-aminocephalosporanic acid
DE2132883A1 (de) *	1970-07-08	1972-01-13	Ciba Geigy Ag	Cephemverbindungen
US3932465A (en) *	1970-07-08	1976-01-13	Ciba-Geigy Corporation	3-R-methyl-7-amino-ceph-em-4-carboxylic acid compounds
GB1399086A (en) *	1971-05-14	1975-06-25	Glaxo Lab Ltd	Cephalosporin compounds
US4343937A (en) *	1971-06-02	1982-08-10	Merck & Co., Inc.	3-Substituted-7-methoxy-7-amino-3-cephem-4-carboxylic acids
SU589918A3 (ru) *	1971-07-14	1978-01-25	Мерк Энд Ко Инк (Фирма)	Способ получени сложного эфира 3-замещенной метил-7-ациломидо-7-метокси-2-цефем -4- карбоноаой кислоты
JPS5653557B2 (nl) *	1973-10-15	1981-12-19
CH605997A5 (nl) *	1974-08-30	1978-10-13	Ciba Geigy Ag
SE432254B (sv) *	1975-02-04	1984-03-26	Fujisawa Pharmaceutical Co	Analogiforfarande for framstellning av 3-substituerade 7-(alfa,alfa-disubstituerade acetamido)-3-cefem-4-karboxylsyror
GB1547165A (en) *	1975-08-15	1979-06-06	Beecham Group Ltd	3-carbamoylbenzyl and 3-(carbamoylpyridylmethyl)-cephems
GB1575803A (en) *	1976-03-09	1980-10-01	Fujisawa Pharmaceutical Co	3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
US4165430A (en) *	1976-03-19	1979-08-21	Glaxo Laboratories Limited	Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
JPS5946237B2 (ja) *	1976-04-02	1984-11-10	武田薬品工業株式会社	セフアロスポリン誘導体およびその製造法
DE2760484C2 (nl) *	1976-04-14	1992-12-03	Takeda Chemical Industries, Ltd., Osaka, Jp
GB1565941A (en)	1977-02-08	1980-04-23	Toyama Chemical Co Ltd	Process for producing 7-(substituted)amino-3-substituted thiomethyl cephem carboxylic acids
ES467601A1 (es) *	1977-03-12	1979-06-16	Hoechst Ag	Procedimiento para la preparacion de derivados de cefem.
DE2714880A1 (de) *	1977-04-02	1978-10-26	Hoechst Ag	Cephemderivate und verfahren zu ihrer herstellung
US4148997A (en) *	1977-11-07	1979-04-10	Yeda Research And Development Co., Ltd.	7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives
AR229883A1 (es) *	1978-05-26	1983-12-30	Glaxo Group Ltd	Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
DE2822861A1 (de) *	1978-05-26	1979-11-29	Hoechst Ag	Cephemderivate und verfahren zu ihrer herstellung
JPS6027677B2 (ja)	1978-07-06	1985-06-29	富山化学工業株式会社	７−置換又は非置換アミノ−３−置換チオメチルセフエムカルボン酸類の新規製造法
NZ191937A (en)	1978-10-27	1982-09-07	Glaxo Group Ltd	Cephalosporin anti-biotics with a 3-alkyl-1,2,3-triazolium-1-ylmethyl group at the 3-position
NZ192127A (en) *	1978-11-15	1982-12-21	Glaxo Group Ltd	Cephalosporin antibiotics
AT367766B (de) *	1979-02-23	1982-07-26	Glaxo Group Ltd	Verfahren zur herstellung von neuen cephalosporin-antibiotika
JPS55139387A (en)	1979-04-19	1980-10-31	Yamanouchi Pharmaceut Co Ltd	Novel synthetic method of 7-amino-3-heterocyclic thiomethyl-delta3-carboxylic acids
JPS55153790A (en)	1979-05-17	1980-11-29	Yamanouchi Pharmaceut Co Ltd	Preparation of 7-amino-3-heterocyclic thiomethyl-delta3- cephem-4-carboxylic acid
FR2461713A1 (fr) *	1979-07-19	1981-02-06	Roussel Uclaf	Nouvelles alcoyloximes substituees derivees de l'acide 7-(2-amino 4-thiazolyl) acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
NZ198350A (en) *	1980-09-25	1985-02-28	Toyama Chemical Co Ltd	Cephalosporins and intermediates;pharmaceutical compositions
EP0061234A3 (en) *	1981-03-05	1983-11-16	Beecham Group Plc	Cephalosporin derivatives, process for their preparation and pharmaceutical preparations containing them
EP0074611B1 (en) *	1981-09-10	1987-07-22	Takeda Chemical Industries, Ltd.	Method for production of cephalosporin compounds
JPS6064986A (ja) *	1983-09-20	1985-04-13	Toyama Chem Co Ltd	セファロスポリン類の製造法
GB2161476B (en) *	1984-05-25	1988-01-27	Toyama Chemical Co Ltd	2-aminothiazolyl-2-methoxyimino acetamides and their use in preparing cephalosporins
CA1293719C (en) *	1986-09-22	1991-12-31	Takao Takaya	Cephem compounds and processes for preparation thereof

1981
- 1981-09-14 NZ NZ198350A patent/NZ198350A/en unknown
- 1981-09-16 CA CA000386066A patent/CA1204735A/en not_active Expired
- 1981-09-16 PH PH26215A patent/PH18072A/en unknown
- 1981-09-16 GB GB8128011A patent/GB2089339B/en not_active Expired
- 1981-09-17 AU AU75438/81A patent/AU550330B2/en not_active Expired
- 1981-09-19 IN IN1045/CAL/81A patent/IN155375B/en unknown
- 1981-09-23 DE DE3152934A patent/DE3152934C2/de not_active Expired - Lifetime
- 1981-09-23 DE DE3152931A patent/DE3152931C2/de not_active Expired
- 1981-09-23 DE DE3152935A patent/DE3152935C2/de not_active Expired - Lifetime
- 1981-09-23 NL NL8104386A patent/NL8104386A/nl not_active Application Discontinuation
- 1981-09-23 DE DE3152932A patent/DE3152932C2/de not_active Expired - Lifetime
- 1981-09-23 US US06/304,912 patent/US4489072A/en not_active Expired - Lifetime
- 1981-09-23 IT IT49348/81A patent/IT1172201B/it active
- 1981-09-23 DE DE19813137854 patent/DE3137854A1/de active Granted
- 1981-09-24 PT PT73727A patent/PT73727B/pt unknown
- 1981-09-24 NO NO813252A patent/NO161117C/no unknown
- 1981-09-24 DK DK421881A patent/DK163877C/da active
- 1981-09-24 AT AT0410981A patent/AT375082B/de not_active IP Right Cessation
- 1981-09-24 SE SE8105658A patent/SE453090B/sv not_active IP Right Cessation
- 1981-09-24 MX MX7609A patent/MX155025A/es unknown
- 1981-09-24 ES ES505760A patent/ES505760A0/es active Granted
- 1981-09-24 HU HU812759A patent/HU185850B/hu unknown
- 1981-09-24 FI FI812980A patent/FI75575C/fi not_active IP Right Cessation
- 1981-09-24 LU LU83650A patent/LU83650A1/fr unknown
- 1981-09-25 DD DD81233599A patent/DD202436A5/de unknown
- 1981-09-25 CH CH6202/81A patent/CH652129A5/de not_active IP Right Cessation
- 1981-09-25 CH CH4519/84A patent/CH651837A5/de not_active IP Right Cessation
- 1981-09-25 RO RO112113A patent/RO86825B/ro unknown
- 1981-09-25 CH CH4520/84A patent/CH652130A5/de not_active IP Right Cessation
- 1981-09-25 DD DD81247292A patent/DD208351A5/de unknown
- 1981-09-25 RO RO112111A patent/RO86823B/ro unknown
- 1981-09-25 RO RO81105405A patent/RO82689A/ro unknown
- 1981-09-25 FR FR8118156A patent/FR2509310B1/fr not_active Expired
- 1981-09-25 CH CH4521/84A patent/CH652128A5/de not_active IP Right Cessation
- 1981-09-25 RO RO112112A patent/RO86824B/ro unknown
- 1981-09-26 EG EG543/81A patent/EG17373A/xx active
1982
- 1982-08-02 ES ES514670A patent/ES514670A0/es active Granted
- 1982-08-02 ES ES514669A patent/ES514669A0/es active Granted
- 1982-08-02 ES ES514671A patent/ES8306157A1/es not_active Expired
- 1982-09-22 FR FR8215992A patent/FR2511377B1/fr not_active Expired
1983
- 1983-01-07 AR AR29180883A patent/AR240645A1/es active
- 1983-02-18 AT AT0055683A patent/AT378193B/de not_active IP Right Cessation
- 1983-02-18 AT AT0055483A patent/AT378961B/de not_active IP Right Cessation
- 1983-02-18 AT AT0055583A patent/AT378962B/de not_active IP Right Cessation
- 1983-06-17 PH PH29076A patent/PH19147A/en unknown
- 1983-06-17 PH PH29075A patent/PH19251A/en unknown
- 1983-06-17 PH PH29078A patent/PH18484A/en unknown
- 1983-06-17 PH PH29077A patent/PH20221A/en unknown
- 1983-09-01 CA CA000435930A patent/CA1200541A/en not_active Expired
1984
- 1984-01-27 GB GB08402249A patent/GB2135304B/en not_active Expired
- 1984-01-27 GB GB08402250A patent/GB2136420B/en not_active Expired
- 1984-08-29 IN IN603/CAL/84A patent/IN159126B/en unknown
- 1984-08-29 IN IN601/CAL/84A patent/IN158589B/en unknown
- 1984-08-29 IN IN602/CAL/84A patent/IN158590B/en unknown
- 1984-09-26 US US06/654,681 patent/US4673738A/en not_active Expired - Lifetime
1985
- 1985-11-13 AU AU49862/85A patent/AU558649B2/en not_active Expired
- 1985-11-13 AU AU49861/85A patent/AU568033B2/en not_active Expired
1986
- 1986-01-16 SE SE8600193A patent/SE468479B/sv not_active IP Right Cessation
- 1986-01-16 SE SE8600194A patent/SE468476B/sv not_active IP Right Cessation
- 1986-01-16 SE SE8600195A patent/SE468477B/sv not_active IP Right Cessation
- 1986-01-16 SE SE8600192A patent/SE468478B/sv not_active IP Right Cessation
- 1986-03-29 KR KR1019860002383A patent/KR860000932B1/ko not_active IP Right Cessation
1987
- 1987-01-15 FI FI870153A patent/FI80041C/fi not_active IP Right Cessation
- 1987-03-06 US US07/022,433 patent/US4879381A/en not_active Expired - Lifetime
1991
- 1991-05-24 US US07/707,221 patent/US5144027A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PT73727B (en)	1982-12-30
ATA55483A (de)	1985-03-15
SE468479B (sv)	1993-01-25
ES8301998A1 (es)	1983-01-01
FR2511377A1 (fr)	1983-02-18
NO161117B (no)	1989-03-28
AU558649B2 (en)	1987-02-05
RO86825B (ro)	1985-05-31
AU568033B2 (en)	1987-12-10
RO82689A (ro)	1983-11-01
US4879381A (en)	1989-11-07
ATA55683A (de)	1984-11-15
IN159126B (nl)	1987-03-28
GB8402249D0 (en)	1984-02-29
RO82689B (ro)	1983-10-30
FI870153A (fi)	1987-01-15
RO86823A (ro)	1985-05-20
NL8104386A (nl)	1982-04-16
DE3152935C2 (nl)	1992-07-16
CA1200541A (en)	1986-02-11
GB2089339A (en)	1982-06-23
ES514671A0 (es)	1983-05-01
SE8105658L (sv)	1982-05-05
AT378961B (de)	1985-10-25
CH652129A5 (de)	1985-10-31
KR860000932B1 (ko)	1986-07-19
FI75575B (fi)	1988-03-31
SE8600195D0 (sv)	1986-01-16
SE8600194L (sv)	1986-01-16
FR2509310B1 (fr)	1985-08-02
PH18484A (en)	1985-08-02
GB8402250D0 (en)	1984-02-29
FI870153A0 (fi)	1987-01-15
RO86824B (ro)	1985-05-31
ATA55583A (de)	1985-03-15
IN158589B (nl)	1986-12-13
RO86825A (ro)	1985-05-20
DK163877B (da)	1992-04-13
NO813252L (no)	1982-03-26
ES505760A0 (es)	1983-01-01
DE3137854C2 (nl)	1987-06-19
PH19147A (en)	1986-01-15
RO86823B (ro)	1985-05-31
GB2135304B (en)	1985-03-27
FR2509310A1 (fr)	1983-01-14
GB2136420B (en)	1985-05-01
SE468476B (sv)	1993-01-25
MX155025A (es)	1988-01-20
SE468477B (sv)	1993-01-25
ES8306155A1 (es)	1983-05-01
IT8149348A0 (it)	1981-09-23
NZ198350A (en)	1985-02-28
ES8306157A1 (es)	1983-05-01
ES8306156A1 (es)	1983-05-01
AU4986185A (en)	1986-03-20
AT375082B (de)	1984-06-25
HU185850B (en)	1985-04-28
IN155375B (nl)	1985-01-19
DD202436A5 (de)	1983-09-14
DE3152934C2 (nl)	1990-01-18
CH652130A5 (de)	1985-10-31
SE453090B (sv)	1988-01-11
GB2136420A (en)	1984-09-19
CH652128A5 (de)	1985-10-31
SE8600193D0 (sv)	1986-01-16
DE3152932C2 (nl)	1990-02-08
GB2135304A (en)	1984-08-30
LU83650A1 (fr)	1982-01-21
AU550330B2 (en)	1986-03-20
SE8600192L (sv)	1986-01-16
DD208351A5 (de)	1984-05-02
AU4986285A (en)	1986-04-24
ES514669A0 (es)	1983-05-01
SE8600192D0 (sv)	1986-01-16
SE8600193L (sv)	1986-01-16
RO86824A (ro)	1985-05-20
DE3137854A1 (de)	1982-04-15
DE3152931C2 (nl)	1989-10-05
PH19251A (en)	1986-02-17
US5144027A (en)	1992-09-01
DK421881A (da)	1982-04-15
US4673738A (en)	1987-06-16
FI812980L (fi)	1982-03-26
GB2089339B (en)	1985-04-24
US4489072A (en)	1984-12-18
EG17373A (en)	1990-12-30
PH18072A (en)	1985-03-18
SE8600195L (sv)	1986-01-16
CA1204735A (en)	1986-05-20
ES514670A0 (es)	1983-05-01
AR240645A1 (es)	1990-07-31
DK163877C (da)	1992-09-14
FI80041B (fi)	1989-12-29
PT73727A (en)	1981-10-01
AU7543881A (en)	1982-04-01
ATA410981A (de)	1983-11-15
SE8600194D0 (sv)	1986-01-16
FI75575C (fi)	1988-07-11
IN158590B (nl)	1986-12-13
FI80041C (fi)	1990-04-10
AT378193B (de)	1985-06-25
SE468478B (sv)	1993-01-25
PH20221A (en)	1986-10-23
FR2511377B1 (fr)	1985-12-13
IT1172201B (it)	1987-06-18
AT378962B (de)	1985-10-25
CH651837A5 (de)	1985-10-15

Publication	Publication Date	Title
NO161117C (no)	1989-07-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO158099C (no)	1988-07-13	Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO156864B (no)	1987-08-31	Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO159531C (no)	1989-01-11	Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO164835C (no)	1990-11-21	Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO159446C (no)	1988-12-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO165239C (no)	1991-01-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no)	1991-01-09	Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO166320C (no)	1991-07-03	Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO152129C (no)	1985-08-07	Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO164301C (no)	1990-09-19	Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO831610L (no)	1983-11-09	Fremgangsmaate for fremstilling av terapeutisk aktive oxicamderivater.
NO814136L (no)	1982-06-07	Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-arylalkyl-3-fenyl-3-notropanol-derivater
NO156787C (no)	1987-11-25	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO158183C (no)	1988-07-27	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO159654C (no)	1989-01-25	Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO161562C (no)	1989-08-30	Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO164169C (no)	1990-09-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzothiazinderivater.
NO158941C (no)	1988-11-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO161559C (no)	1989-08-30	Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO160079C (no)	1989-03-08	Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO155840C (no)	1987-06-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive taurin-derivater.
NO158739C (no)	1988-10-26	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no)	1989-04-26	Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO160512C (no)	1989-04-26	Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.